IGF-1 (insulin-like growth factor 1) is the main downstream mediator of growth hormone, and its concentration changes dramatically with age and sex. A single fixed reference range cannot capture that, so endocrinologists convert a measured value into a standard deviation score (SDS) against the matched population. This calculator performs that conversion.
How it works
The tool uses the LMS method, the standard approach for skewed biological
measurements. For a given age and sex, three reference parameters are looked up
and interpolated: L (the Box-Cox power that corrects skewness), M (the
median), and S (the coefficient of variation). The SDS is then:
if L ≠ 0: SDS = ((value / M)^L − 1) / (L × S)
if L = 0: SDS = ln(value / M) / S
This is mathematically equivalent to a z-score on the normalised, skewness- corrected scale. A result is interpolated between the two nearest tabulated ages so that intermediate ages are handled smoothly.
Why IGF-1 needs age- and sex-specific scoring
Raw IGF-1 in ng/mL is almost meaningless without context. A result of 300 ng/mL could be very high-normal for a 5-year-old, mid-range for a 14-year-old at peak puberty, and elevated-to-suspect-acromegaly for a 50-year-old. Concentrations typically:
- Rise steeply through childhood
- Peak in mid-puberty, often reaching their highest lifetime values
- Decline gradually but substantially through adulthood and into older age
- Differ between males and females particularly during the pubertal window
The SDS expresses where a result sits within the expected distribution for that exact age and sex, making it the only meaningful way to compare one patient’s result to another or track a patient’s trajectory over time.
Clinical context: what the SDS means
| SDS range | Interpretation |
|---|---|
| Below −2.0 | Low; consistent with possible growth hormone deficiency or other cause of low IGF-1 |
| −2.0 to −1.0 | Low-normal; worth monitoring, especially in short children |
| −1.0 to +1.0 | Mid-normal range |
| +1.0 to +2.0 | High-normal |
| Above +2.0 | Elevated; may warrant investigation for excess growth hormone |
A low SDS is used as a screening marker for growth hormone deficiency in children with poor growth, but it is not diagnostic alone — stimulation tests are required to confirm GHD. A markedly elevated SDS in an adult raises concern for acromegaly and typically leads to an oral glucose suppression test. IGF-1 SDS also guides dosing during growth hormone replacement therapy: the goal during treatment is usually to maintain SDS between −1 and +1, avoiding prolonged elevation above +2.
Example, notes, and limits
A 10-year-old girl with an IGF-1 of 350 ng/mL scored against a reference with
M = 220, S = 0.30, L = 0.7 yields an SDS near +1.8 — high-normal. The
reference panel built into this tool is illustrative; IGF-1 assays vary widely
between manufacturers, so for clinical work you must substitute your laboratory’s
own assay-specific LMS table. Treat an SDS outside the −2 to +2 band as a
prompt for further evaluation, never as a standalone diagnosis.